US 9846160
Ganglioside GD2 as a marker and target on cancer stem cells
granted A61KA61K2039/505A61K31/4192
Quick answer
US patent 9846160 (Ganglioside GD2 as a marker and target on cancer stem cells) held by The Board of Regents of the University of Texas System expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K31/4192, A61K31/4196, A61K39/39558